LYEL
#3232
Lyell Immunopharma, Inc. - Common Stock
14.3 3 USD
-0.05%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-4.53%
Variación mensual
+3.99%
Variación en los últimos 6 meses
-40.76%
Cambio anual
-40.76%
Cierres anteriores
15.0 1
Open
14.3 3
Mínimo
14.3 3
High
14.3 3
Volumen
34
Financials
- Market Capitalization 334.38 M
- Employee 161
- Founded 2018
- CEO N/A
- Website www.lyell.com
- Headquarter Delaware, United States
- FIGI BBG00RNXFN14
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.92
Relación precio/flujo de caja
14.61 K
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3215 |  HELP Cybin Inc. - Common Stock | 6.70 USD | -2.47% | +14.92% | +52.27% | -25.31% | 345.93 M USD | ||
| 3228 |  CTNM Contineum Therapeutics, Inc. - Common stock | 14.62 USD | -3.75% | -2.21% | +20.53% | -4.26% | 337.71 M USD | ||
| 3234 |  IMRX Immuneering Corporation - Class A Common Stock | 5.16 USD | +0.98% | +0.98% | +20.56% | +23.15% | 333.84 M USD | ||
| 3249 |  ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 4.62 USD | -5.33% | -1.49% | +19.07% | +237.23% | 328.88 M USD |